Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2004

Open Access 01-12-2004 | Review

Acromegaly Quality of Life Questionnaire (AcroQoL)

Authors: Xavier Badia, Susan M Webb, Luis Prieto, Nuria Lara

Published in: Health and Quality of Life Outcomes | Issue 1/2004

Login to get access

Abstract

Acromegaly is a chronic disease with an important impact on patients, Health Related Quality of Life (HRQoL). The ability to effectively measure Health Related Quality of Life is central to describing the impacts of disease or treatment upon the patient, therefore the importance of having a disease specific questionnaire for acromegaly. For the development of the AcroQoL questionnaire different sources of information were used: first a literature search was performed to identify relevant papers describing the impact of acromegaly in HRQoL, second the main domains of impact on HRQoL were identified by 10 experts endocrinologists, and third ten in-depth semi-structured interviews were conducted in acromegalic patients to identify domains and items related to the self-perceived impact of acromegaly in patients' life. After a proper qualitative analysis a preliminary 38 item questionnaire was obtained. Rasch analysis concluded with a final 22 item questionnaire. The measurement properties (validity and reliability) of the resulting final questionnaire were tested and compared using standard procedures (Cronbach's Alpha and item-total correlation). The evaluation of the item parameters confirmed the construct validity of the new instrument. Responsiveness to change was assessed in a small sample of 32 acromegalic patients with active disease in Spain who were administered the AcroQoL and the generic questionnaire EuroQoL 5-D. The results showed a statistically significant relationship between all the dimensions of AcroQoL and the VAS (visual analogic scale) of EQ-5D. An improvement in the global score of AcroQoL was related to a global improvement in the VAS of the EQ-5D.
Following the current recommended standard methodology the Spanish questionnaire was translated into eleven other languages.
Appendix
Available only for authorised users
Literature
1.
go back to reference Patrick DL, Erickson P: Health Status and Health Policy. Oxford University Press, New York 1993. Patrick DL, Erickson P: Health Status and Health Policy. Oxford University Press, New York 1993.
2.
go back to reference Mc Dowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. 2 Edition Oxford University Press, New York 1996. Mc Dowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. 2 Edition Oxford University Press, New York 1996.
3.
go back to reference Etxabe J, Gaztambide S, Latorre P, Vazquez JA: Acromegaly: an epidemiological study. J Endocrinol Invest 1993, 16: 181–7.PubMedCrossRef Etxabe J, Gaztambide S, Latorre P, Vazquez JA: Acromegaly: an epidemiological study. J Endocrinol Invest 1993, 16: 181–7.PubMedCrossRef
4.
go back to reference Coskeran P: Management and treatment of patients with acromegaly. Nurs Times 1999, 95: 50–2.PubMed Coskeran P: Management and treatment of patients with acromegaly. Nurs Times 1999, 95: 50–2.PubMed
5.
go back to reference Pantanetti P, Sonino N, Arnaldi G, Boscaro M: Self image and quality of life in acromegaly. Pituitary 2002, 5: 17–9. 10.1023/A:1022145116901PubMedCrossRef Pantanetti P, Sonino N, Arnaldi G, Boscaro M: Self image and quality of life in acromegaly. Pituitary 2002, 5: 17–9. 10.1023/A:1022145116901PubMedCrossRef
6.
go back to reference Yamamoto T, Nakamura H, Ogawa T, Saga T, Ishikawa K: Acromegaly with multiple cardiovascular complications-cardiomyopathy, chordae rupture of mitral valve, myocardial infarction and sick sinus syndrome. Intern Med 2003, 42: 700–3.PubMedCrossRef Yamamoto T, Nakamura H, Ogawa T, Saga T, Ishikawa K: Acromegaly with multiple cardiovascular complications-cardiomyopathy, chordae rupture of mitral valve, myocardial infarction and sick sinus syndrome. Intern Med 2003, 42: 700–3.PubMedCrossRef
7.
go back to reference Ezzat S: Living with acromegaly. Endocrinol Metab Clin North Am 1992, 21: 753–760.PubMed Ezzat S: Living with acromegaly. Endocrinol Metab Clin North Am 1992, 21: 753–760.PubMed
8.
go back to reference Furman K, Ezzat S: Psychological features of acromegaly. Psychother Psychosom 1998, 67: 147–153. 10.1159/000012275PubMedCrossRef Furman K, Ezzat S: Psychological features of acromegaly. Psychother Psychosom 1998, 67: 147–153. 10.1159/000012275PubMedCrossRef
9.
go back to reference Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M: Slow release lanreotide treatment in acromegaly: Effects on quality of life. Psychother Psychosom 1999, 68: 165–167. 10.1159/000012326PubMedCrossRef Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M: Slow release lanreotide treatment in acromegaly: Effects on quality of life. Psychother Psychosom 1999, 68: 165–167. 10.1159/000012326PubMedCrossRef
10.
go back to reference Flitsch J, Spitzner S, Lüdecke DK: Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 2000, 108: 480–485. 10.1055/s-2000-8144PubMedCrossRef Flitsch J, Spitzner S, Lüdecke DK: Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 2000, 108: 480–485. 10.1055/s-2000-8144PubMedCrossRef
11.
go back to reference Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperín I, Obiols G, Astorga R: Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 2002, 57: 251–258. 10.1046/j.1365-2265.2002.01597.xCrossRef Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperín I, Obiols G, Astorga R: Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 2002, 57: 251–258. 10.1046/j.1365-2265.2002.01597.xCrossRef
12.
go back to reference Fava GA, Sonino N, Morphy MA: Psychosomatic view of endocrine disorders. Psychother Psychosom 1993, 59: 20–33.PubMedCrossRef Fava GA, Sonino N, Morphy MA: Psychosomatic view of endocrine disorders. Psychother Psychosom 1993, 59: 20–33.PubMedCrossRef
13.
go back to reference Rasch G: Probabilistic Models for Some Intelligence and Attainment Tests. Mesa Press, Chicago 1993. Rasch G: Probabilistic Models for Some Intelligence and Attainment Tests. Mesa Press, Chicago 1993.
14.
go back to reference Wright BD, Master GN: Rating Scale Analysis. MESA Press, Chicago 1982. Wright BD, Master GN: Rating Scale Analysis. MESA Press, Chicago 1982.
15.
go back to reference Herdman M, Fox-Rushby J, Badia X: A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998, 7: 323–335.PubMedCrossRef Herdman M, Fox-Rushby J, Badia X: A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998, 7: 323–335.PubMedCrossRef
16.
go back to reference Christ ER, Simpson HL, Breen L, Sonksen PH, Russell-Jones DL, Kohner EM: The effect of growth hormones (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. Clin Endocrinol (Oxf) 2003, 58: 309–15. 10.1046/j.1365-2265.2003.01714.xCrossRef Christ ER, Simpson HL, Breen L, Sonksen PH, Russell-Jones DL, Kohner EM: The effect of growth hormones (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. Clin Endocrinol (Oxf) 2003, 58: 309–15. 10.1046/j.1365-2265.2003.01714.xCrossRef
Metadata
Title
Acromegaly Quality of Life Questionnaire (AcroQoL)
Authors
Xavier Badia
Susan M Webb
Luis Prieto
Nuria Lara
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2004
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-2-13

Other articles of this Issue 1/2004

Health and Quality of Life Outcomes 1/2004 Go to the issue